UNSPSC 51102904: Pyrimethamine/sulfadoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP101. This VA Drug Class (AP101) classifies this compound as belonging to the group ANTIMALARIALS.

UNSPSC 51102904 Pyrimethamine/sulfadoxine is a Commodity code covering pharmaceutical products; however, the recent state and local opportunities posted under this code show little direct alignment with the nominal scope. The opportunities represent a broader range of pharmacy and medical supply procurement activity — naloxone and drug deactivation systems, therapeutic pharmacy initiative capacity assessment, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — that do not specifically target pyrimethamine/sulfadoxine antimalarial compounds. Issuing bodies include county health agencies (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue departments (City of Tampa Fire Department Rescue Division), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance). The procurement notices span RFPs, RFQs, and competitive bidding processes, with one RFI serving as preliminary market intelligence rather than a formal solicitation.

Recent opportunities are concentrated in Florida, Texas, and Minnesota, with participation from Oregon through MMCAP's multistate vehicle. Representative solicitations include Seminole County's IFB60459723LAS (due July 26, 2023) for naloxone and safe drug deactivation systems; the City of Tampa's 26P00145 IFB for medical and first aid supplies (due March 13, 2026, estimated contract value $700,000.00, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount); the Texas HHS RFI HHS0017013 (due April 3, 2026) exploring direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code shows recent activity but limited specificity to the pyrimethamine/sulfadoxine category itself, suggesting either miscoding in the source data or a very narrow market niche within the broader pharmaceutical and medical supply procurement space.